Clifford A. Reid, Ph.D., is our co-founder and has served as our President, Chief Executive Officer and Chairman since July 2005 and as a member of our board of directors since July 2005. From March 2003 to September 2005, Dr. Reid was Vice President of Collaborative Solutions at Open Text Corporation, a software company. In 1995, Dr. Reid co-founded Eloquent, Inc., a digital video communications company, and served as its Chief Executive Officer until 1999 and as its Chairman until 2003, when it was acquired by Open Text. In 1988, Dr. Reid co-founded Verity, Inc., an enterprise text search engine company, and served as its Vice President of Engineering from 1988 to 1992 and as its Executive Vice President from 1992 to 1993. Dr. Reid received a B.S. in Physics from the Massachusetts Institute of Technology, an M.B.A. from Harvard University and a Ph.D. in Management Science and Engineering from Stanford University.

Ajay Bansal has served as our Chief Financial Officer since May 2010. From June 2009 to January 2010, Mr. Bansal served as Chief Financial Officer and Executive Vice President of Business Development at Lexicon Pharmaceuticals, Inc., a biopharmaceutical company. From December 2007 to October 2008, Mr. Bansal served as Chief Financial Officer and Executive Vice President of Finance of Tercica, Inc., a biopharmaceutical company acquired by the Ipsen Group in October 2008. He also served as Chief Financial Officer and Senior Vice President of Finance of Tercica from March 2006 until December 2007. From February 2003 to January 2006, Mr. Bansal served as Vice Present of Finance and Administration and Chief Financial Officer of Nektar Therapeutics, a biopharmaceutical company. From July 2002 to February 2003, Mr. Bansal served as Director of Operations Analysis at Capital One Financial, a bank holding company. From August 1998 to June 2002, Mr. Bansal was at Mehta Partners LLC, a financial advisory firm, where he was named partner in January 2000. Prior to joining Mehta Partners, Mr. Bansal spent more than ten years in management roles at Novartis, a pharmaceuticals company, and in consulting at Arthur D. Little, Inc., McKinsey & Company, Inc. and ZS Associates. Mr. Bansal received a B.S. in Mechanical Engineering from the Indian Institute of Technology (Delhi) and an M.S. in Operations Management and an M.B.A. from Northwestern University.

Radoje Drmanac, Ph.D., is our co-founder and has served as our Chief Scientific Officer since July 2005. In 2001, Dr. Drmanac co-founded Callida Genomics, Inc., a DNA sequencing company, and served as Callida’s Chief Scientific Officer from 2001 to 2004 and has served as its President since 2004. In 1994, Dr. Drmanac co-founded Hyseq, Inc., a DNA array technology company that became Hyseq Pharmaceuticals, Inc. and later merged with Variagenics, Inc. to become Nuvelo, Inc., and served as its Senior Vice President of Research from 1994 to 1998 and as its Chief Scientific Officer from 1998 to 2001. Prior to that, Dr. Drmanac served as a group leader at Argonne National Laboratory. Dr. Drmanac received a B.S., M.S. and Ph.D. in Molecular Biology from the University of Belgrade.

Jill Hagenkord joined Complete Genomics as Chief Medical Officer in August 2011. In 2009 Dr. Hagenkord founded iKaryos Diagnostics, a clinically-focused cancer diagnostics company in Palo Alto, California that operates in collaboration with Creighton University and Creighton Medical Laboratories in Omaha, Nebraska. While at iKaryos, Dr. Hagenkord also served as an associate professor at Creighton and director of molecular pathology and clinical genomics in its Department of Pathology. Dr. Hagenkord continues to serve on the iKaryos Board of Directors. Prior to joining iKaryos, Dr. Hagenkord worked as a pathologist for Deltagen, Inc., a provider of drug discovery tools for the biopharmaceutical industry. Dr. Hagenkord received her MD from Stanford University School of Medicine in 1999 and did her residency training in pathology at the University of California at San Francisco and the University of Iowa. She completed fellowships in pathology/oncology informatics and molecular genetic pathology at the University of Pittsburgh.

Bill Homan joined Complete Genomics as Senior Vice President, General Counsel and Secretary in March 2012. Mr. Homan was Senior Vice President, General Counsel and Secretary of Varian, Inc. from April 1999 until it was acquired by Agilent Technologies, Inc. in May 2010. Prior to that, he was Associate General Counsel of Varian Associates, Inc., and started his legal career with a large San Francisco law firm. Mr. Homan received a Bachelor’s degree in Economics and Political Science from Virginia Tech, and his law degree from the University of Virginia.

Bruce Martin has served as our Senior Vice President of Product Development since March 2010. From May 2007 to March 2010, Mr. Martin was our Vice President of Product Development. From 2005 to May 2007, Mr. Martin served as Vice President of Product Strategy at PSS Systems, Inc., an internet software company. From 2002 to 2003, Mr. Martin served as Chief Technical Officer of Openwave Systems Inc., a software company. Mr. Martin received a B.S. in Computer Science and Electrical Engineering from the University of California, Davis.

Keith Raffel joined Complete Genomics as Senior Vice President and Chief Commercial Officer in June 2011.  In 1996, Mr. Raffel founded UpShot Corporation, Silicon Valley’s first company based on a cloud computing model, where he served as CEO and Chairman.  After UpShot’s acquisition by Siebel Systems in 2003, he was named a group vice president of Siebel.  When Siebel itself was purchased by Oracle Corporation in 2006, he became a group vice president at Oracle.  Prior to founding UpShot, Mr. Raffel had a series of executive roles at Echelon Corporation and served as general manager of international at ROLM Corporation where he oversaw the opening of the first office of a foreign telecommunications company in Beijing. For three years before joining Complete Genomics, Mr. Raffel worked as a novelist.  His published books include Drop By Drop and the national bestseller Smasher.  Mr. Raffel received an A.B. and J.D. from Harvard and an M.Litt. from Oxford.

Kathleen Swift has served as our Vice President of Human Resources since May 2011.  She oversees staffing and talent recruitment, organizational development, employee benefits and compensation strategies.  Prior to joining Complete Genomics, Ms. Swift served as Vice President of Human Resources at Opnext where she was responsible for talent recruitment, organizational development, employee compensation and benefits strategies, and real estate and facilities management. From September 2007 through January 2010, Ms. Swift managed a global human resources organization as well as the real estate and facilities functions for Extreme Networks. From February 2005 until its acquisition by Motorola in July 2007, Ms. Swift held the position of vice president of HR with Terayon.  Ms. Swift has also held a variety of director and manager-level HR positions at Avanex, Com21, Questlink and Hitachi. Ms. Swift received a Bachelor’s degree in Business Administration with honors from the California State University at Chico.